Young Blood and the Pursuit of Eternal Youth
Ambrosia Health was offering a novel procedure: young blood transfusions it claimed could extend youth. The only problem was the FDA.
Photographer: Oscar Gonzalez/NurPhoto via Getty Images
This article is for subscribers only.
A company called Ambrosia Health signed up about 150 patients for a novel anti-aging procedure: young blood plasma transfusions. The only problem was the FDA. This week on Decrypted, the story of a startup that claimed it could restore lost youth with young people's blood. We’ll hear from a patient who got the treatment, the researchers who say it endangered patients, and the scientists who believe the idea isn’t as crazy as it seems.